Dune Medical develops, manufactures, and commercializes innovative products that improve the effectiveness and outcome of cancer therapy by providing real-time tissue characterization systems to guide surgical and diagnostic decisions. We accomplish this by identifying significant unmet clinical and market needs and investing in core technologies to develop products that improve patient care, build shareholder value, and create an exciting environment for employees.
Dune Medical Devices was founded in 2002 by Dr. Dan Hashimshony to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the real time ability to identify cancerous tissues and react immediately, this technology holds the promise for a broad range of surgical and diagnostic applications.
Dune Medical Devices is a privately held company with offices in the U.S. and Israel. Meet our management team and board of directors.
We’re interested in hearing from you
More and more breast surgeons are interested in the details of the MarginProbe System for intraoperative margin assessment. If you’d like to know more about the technology and the science behind it, contact us. We’ll be happy to provide more information or have one of our sales representatives contact you directly to schedule a product presentation.